• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bronchomediastinal Fistula During Durvalumab Therapy After Chemoradiotherapy in Stage III NSCLC.

作者信息

Sumi Toshiyuki, Ikeda Takumi, Kure Kenichi, Yamada Yuichi, Nakata Hisashi, Mori Yuji

机构信息

Department of Pulmonary Medicine, Hakodate Goryokaku Hospital, Hokkaido, Japan.

Department of Pulmonary Medicine, Hakodate Goryokaku Hospital, Hokkaido, Japan.

出版信息

J Thorac Oncol. 2019 Oct;14(10):1860-1861. doi: 10.1016/j.jtho.2019.06.003. Epub 2019 Jun 13.

DOI:10.1016/j.jtho.2019.06.003
PMID:31300340
Abstract
摘要

相似文献

1
Bronchomediastinal Fistula During Durvalumab Therapy After Chemoradiotherapy in Stage III NSCLC.III期非小细胞肺癌放化疗后使用度伐利尤单抗治疗期间出现支气管纵隔瘘
J Thorac Oncol. 2019 Oct;14(10):1860-1861. doi: 10.1016/j.jtho.2019.06.003. Epub 2019 Jun 13.
2
Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse events.不可切除的晚期非小细胞肺癌患者放化疗序贯度伐利尤单抗治疗：不良反应管理。
Thorac Cancer. 2020 May;11(5):1280-1287. doi: 10.1111/1759-7714.13394. Epub 2020 Mar 11.
3
Development of Bronchopleural Fistula After Durvalumab Consolidation for Stage III Non-Small-Cell Lung Cancer.度伐利尤单抗巩固治疗Ⅲ期非小细胞肺癌后支气管胸膜瘘的发生
Clin Lung Cancer. 2021 Jan;22(1):e18-e24. doi: 10.1016/j.cllc.2020.07.010. Epub 2020 Jul 30.
4
Cost-effectiveness and Budgetary Consequence Analysis of Durvalumab Consolidation Therapy vs No Consolidation Therapy After Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer in the Context of the US Health Care System.在考虑到美国医疗保健系统的情况下，durvalumab 巩固治疗与放化疗后不进行巩固治疗在 III 期非小细胞肺癌中的成本效果和预算后果分析。
JAMA Oncol. 2019 Mar 1;5(3):358-365. doi: 10.1001/jamaoncol.2018.5449.
5
Refractory Severe Esophagitis During Durvalumab Therapy in a Patient With Locally Advanced NSCLC.度伐利尤单抗治疗局部晚期非小细胞肺癌患者期间出现的难治性严重食管炎
J Thorac Oncol. 2019 Feb;14(2):e40-e42. doi: 10.1016/j.jtho.2018.10.153.
6
Life-threatening bronchomediastinal fistula complicating a first cycle of chemotherapy in a stage IV NSCLC case.一名IV期非小细胞肺癌患者在首个化疗周期中出现危及生命的支气管纵隔瘘。
J Thorac Oncol. 2015 Apr;10(4):717-8. doi: 10.1097/JTO.0000000000000373.
7
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer.预测 durvalumab 联合同步放化疗治疗局部晚期非小细胞肺癌后引起的症状性放射性肺炎的因素。
Radiat Oncol. 2022 Jan 15;17(1):7. doi: 10.1186/s13014-021-01979-z.
8
DUART: durvalumab after radiotherapy in patients with unresectable, stage III NSCLC who are ineligible for chemotherapy.度伐利尤单抗联合放疗用于不可切除的 III 期 NSCLC 患者，这些患者由于不适合化疗而无法接受化疗。
Future Oncol. 2021 Dec;17(34):4657-4663. doi: 10.2217/fon-2021-0952. Epub 2021 Nov 15.
9
Patients with unresectable stage III non-small cell lung cancer eligible to receive consolidation therapy with durvalumab in clinical practice based on PACIFIC study criteria.根据 PACIFIC 研究标准，在临床实践中符合接受度伐利尤单抗巩固治疗条件的不可切除 III 期非小细胞肺癌患者。
Respir Investig. 2019 Sep;57(5):466-471. doi: 10.1016/j.resinv.2019.03.011. Epub 2019 May 16.
10
Diagnosis and management of pneumonitis following chemoradiotherapy and immunotherapy in stage III non-small cell lung cancer.放化疗和免疫治疗后 III 期非小细胞肺癌相关肺炎的诊断与管理。
Radiother Oncol. 2024 May;194:110147. doi: 10.1016/j.radonc.2024.110147. Epub 2024 Feb 9.

引用本文的文献

1
Central Airway Invasion of Lung Squamous Cell Carcinoma Causing Bronchomediastinal Fistula and Mediastinitis.肺鳞状细胞癌侵犯中央气道致支气管纵隔瘘及纵隔炎
Respirol Case Rep. 2025 Jun 9;13(6):e70233. doi: 10.1002/rcr2.70233. eCollection 2025 Jun.
2
Esophagomediastinal fistula during durvalumab plus tremelimumab with chemotherapy in angiotensin-converting enzyme 2-positive non-small cell lung cancer: a case report.度伐利尤单抗联合曲美木单抗与化疗治疗血管紧张素转换酶2阳性非小细胞肺癌期间发生食管纵隔瘘：一例报告
Transl Lung Cancer Res. 2024 Oct 31;13(10):2847-2852. doi: 10.21037/tlcr-24-444. Epub 2024 Oct 28.
3
Lung autotransplantation combined with postoperative chemotherapy and immunotherapy: a three-year follow-up case report.
肺自体移植联合术后化疗和免疫治疗：三年随访病例报告。
World J Surg Oncol. 2024 Oct 9;22(1):270. doi: 10.1186/s12957-024-03545-9.
4
Development of postoperative bronchopleural fistula after neoadjuvant immunochemotherapy in non-small cell lung cancer: case reports and review of the literature.新辅助免疫化疗后非小细胞肺癌术后支气管胸膜瘘的发生：病例报告及文献复习。
J Cancer Res Clin Oncol. 2024 Apr 4;150(4):175. doi: 10.1007/s00432-024-05683-9.
5
Tracheomediastinal fistula induced by concurrent chemoradiotherapy in small cell lung cancer: A case report and literature review.小细胞肺癌同步放化疗并发气管-纵隔瘘：1 例报告并文献复习。
Thorac Cancer. 2024 May;15(13):1106-1111. doi: 10.1111/1759-7714.15270. Epub 2024 Mar 25.
6
Bronchoesophageal fistula formation after three courses of nivolumab for carcinoma of unknown primary with a subgroup of lung squamous cell carcinoma.在对原发灶不明癌（其中一部分为肺鳞状细胞癌）进行三个疗程的纳武单抗治疗后发生支气管食管瘘。
Oxf Med Case Reports. 2020 Dec 28;2020(12):omaa116. doi: 10.1093/omcr/omaa116. eCollection 2020 Dec.